# A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

> **NCT07128628** · PHASE2 · RECRUITING · sponsor: **Bausch & Lomb Incorporated** · enrollment: 423 (estimated)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Lifitegrast/Perfluorohexyloctane Fixed Dose Combination
- **DRUG:** Lifitegrast
- **DRUG:** Perfluorohexyloctane
- **DRUG:** Vehicle
- **DRUG:** Vehicle
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT07128628
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-24
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 423 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128628, "A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07128628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*